Report #2839600

Received May 6, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: 17 yrs
State: NY
Recovered: Unknown
Vaccinated: Mar 31, 2025
Onset: Mar 31, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARCEL	VARICELLA (VARIVAX)	MERCK & CO. INC.	UNK	Y015557	—

Symptoms (2)

No adverse eventProduct storage error

Symptom narrative

No additional AE /PQC reported.; HCP calling to report T/E (see T/E case# 02786079. ). HCP stated VARIVAX was administered; This spontaneous report was received from a Nurse and refers to a 17-year-old patient of unknown gender. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 31-Mar-2025, the patient was vaccinated with an improperly storage dose of with Varicella Virus Vaccine Live (Oka-Merck) (VARIVAX), (lot #Y015557, expiration date: 16-Sep-2026) diluted with sterile diluent (MERCK STERILE DILUENT), (indication, expiration date, and lot # were not reported) for prophylaxis. Temperature excursion occurred at -7.8C for 36 minutes. Previous temperature excursion was at (-14.4 C up to -10.4C) -14.0C for 13 minutes. No additional adverse event was reported.

Other medications

Sterile diluent